Last reviewed · How we verify

Quadratus Lumborum Block (QLB) — Competitive Intelligence Brief

Quadratus Lumborum Block (QLB) (Quadratus Lumborum Block (QLB)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Anesthesia/Pain Management.

marketed Anesthesia/Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Quadratus Lumborum Block (QLB) (Quadratus Lumborum Block (QLB)) — University of Alabama at Birmingham. A regional anesthesia technique that blocks nerve signals in the quadratus lumborum muscle region to provide pain relief for abdominal and flank procedures.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Quadratus Lumborum Block (QLB) TARGET Quadratus Lumborum Block (QLB) University of Alabama at Birmingham marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Quadratus Lumborum Block (QLB) — Competitive Intelligence Brief. https://druglandscape.com/ci/quadratus-lumborum-block-qlb. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: